431 related articles for article (PubMed ID: 31578802)
1. Insights into IL-29: Emerging role in inflammatory autoimmune diseases.
Wang JM; Huang AF; Xu WD; Su LC
J Cell Mol Med; 2019 Dec; 23(12):7926-7932. PubMed ID: 31578802
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of interleukin-22 in autoimmune diseases.
Pan HF; Li XP; Zheng SG; Ye DQ
Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
4. IL-38: A New Player in Inflammatory Autoimmune Disorders.
Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations in type I interferon related pathways with autoimmunity.
Delgado-Vega AM; Alarcón-Riquelme ME; Kozyrev SV
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S2. PubMed ID: 20392289
[TBL] [Abstract][Full Text] [Related]
6. Insights into IL-37, the role in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Autoimmun Rev; 2015 Dec; 14(12):1170-5. PubMed ID: 26264940
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
8. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases.
Mora-Arias T; Amezcua-Guerra LM
Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):1. PubMed ID: 31915933
[TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor Pathways in Autoimmune Diseases.
Chen JQ; Szodoray P; Zeher M
Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
[TBL] [Abstract][Full Text] [Related]
10. Targeting IL-33 in autoimmunity and inflammation.
Theoharides TC; Petra AI; Taracanova A; Panagiotidou S; Conti P
J Pharmacol Exp Ther; 2015 Jul; 354(1):24-31. PubMed ID: 25906776
[TBL] [Abstract][Full Text] [Related]
11. IL-33: a potential therapeutic target in autoimmune diseases.
Wang S; Ding L; Liu SS; Wang C; Leng RX; Chen GM; Fan YG; Pan HF; Ye DQ
J Investig Med; 2012 Dec; 60(8):1151-6. PubMed ID: 23076162
[TBL] [Abstract][Full Text] [Related]
12. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and immunobiology of IL-21 in autoimmunity.
Long D; Chen Y; Wu H; Zhao M; Lu Q
J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
15. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K; Beikler T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
[TBL] [Abstract][Full Text] [Related]
16. Current Understanding of IL-37 in Human Health and Disease.
Su Z; Tao X
Front Immunol; 2021; 12():696605. PubMed ID: 34248996
[TBL] [Abstract][Full Text] [Related]
17. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
18. Interferons and autoimmune disorders.
Meyer O
Joint Bone Spine; 2009 Oct; 76(5):464-73. PubMed ID: 19773191
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
20. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Leng RX; Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
